Sagimet Biosciences公司宣布,其Denifanstat和Resmetirom联合用药的1期药代动力学临床试验已开始对首批参与者进行给药。
Sagimet Biosciences公司宣布,其Denifanstat和Resmetirom联合用药的1期药代动力学临床试验已开始对首批参与者进行给药。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.